Dabur Products Allegedly Causing Cancer in US, Canada, Over 5k Complaints Lodged
Dabur products are under the radar in the United States and Canada, as over 5,000 complainants, who are allegedly suffering from ovarian cancer, uterine cancer, and other related health issues, lodged a complaint in state and federal courts.
Dabur India's foreign subsidiaries are under the scanner for manufacturing cancer-causing products in the United States and Canada, where complainants are allegedly suffering from ovarian cancer, uterine cancer, and other related health issues due to hair-relaxer products. Over 5,400 cases have been registered against Dabur in both state and federal courts.
While the complainants have made a legal move, Dabur on the contrary refused the allegations saying, "These allegations are based on unsubstantiated and incomplete study".
There are 27 subsidiary companies of Dabur India globally, while the ones who are facing multiple lawsuits are Namaste Laboratories LLC, Dermoviva Skin Essentials Inc, and Dabur International Ltd. – according to a late-night regulatory filing from the homegrown FMCG and Ayurvedic products maker on Wednesday.
Dabur generated a revenue of Rs 2,867 crore, which was 11.1% in constant currency terms in FY23. According to its latest report, Dabur has eight international manufacturing locations.
Show your support
Dear patron, thank you for being our reader. Readers like you are an inspiration for us to move Agri Journalism forward. We need your support to keep delivering quality Agri Journalism and reach the farmers and people in every corner of rural India.
Every contribution is valuable for our future.
Contribute NowDownload Krishi Jagran Mobile App for more updates on the Latest Agriculture News, Agriculture Quiz, Crop Calendar, Jobs in Agriculture, and more.